Nextgen Bioscience Co., Ltd.
PrivateLast Round
VC Round
Jul 31, 2023
Total Funding Raised
$26.06M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Nextgen Bioscience Co., Ltd. is a biotechnology company that develops therapeutics for autoimmune and fibrotic diseases using its proprietary AI-based drug discovery platform, Fibrain™.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical AI, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Nextgen Bioscience Co., Ltd. Comparables
Compare Nextgen Bioscience Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Standigm | 80% | |
| Oncocross Co., Ltd. | 77% | |
| SyntekaBio Inc | 77% | |
Nextgen Bioscience Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Jul 31, 2023 | ||||
| Series B Extension | Dec 1, 2022 | ||||
| Strategic | Dec 1, 2021 | ||||
| Series B | Jul 1, 2020 | ||||
| Series A | Jul 1, 2019 | ||||
Pre Seed | Dec 1, 2018 |
Nextgen Bioscience Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| DSC Investment | Pre Seed, Series B, Series A |
| Korea Investment Partners | Pre Seed, Series B, Series A |
| Korea Development Bank | Series B |
| Korea Investment Trust Management | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors increased 45% MoM.
- Jan 1, 2026
Monthly visitors increased 39% MoM.
Nextgen Bioscience Co., Ltd. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Nextgen Bioscience Co., Ltd.'s valuation, stock price, and market status.